On 16 June 2025, new post-market surveillance (PMS) requirements came into force in Great Britain under The Medical Devices (Post-market Surveillance Requirements) (Amendment) Regulations 2024 (SI 2024 No. 1368). These changes apply to manufacturers placing medical devices and in vitro diagnostic (IVD) devices on the market in England, Wales and Scotland.